R&D 4 years on: Remembering the COVID-19 pandemic This year, Monday 11th March marked four years since the World Health Organization (WHO) declared COVID-19 a global pandemic.
R&D Disease X is coming. Are we ready? Every great disaster movie begins with a scientist being ignored.
News Nuvalent chases after Nuvation in ROS1 lung cancer New trial data sets up a filing for Nuvalent's new-generation ROS1 inhibitor in NSCLC, although it has an uphill battle to catch rival Nuvation.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
